174 related articles for article (PubMed ID: 9132100)
1. Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease.
Michaelis T; Videen JS; Linsey MS; Ross BD
J Magn Reson Imaging; 1996; 6(2):341-7. PubMed ID: 9132100
[TBL] [Abstract][Full Text] [Related]
2. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Geissler A; Fründ R; Kohler S; Eichhorn HM; Krämer BK; Feuerbach S
Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
Chang L; Ernst T; Speck O; Grob CS
Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
[TBL] [Abstract][Full Text] [Related]
4. Positive correlations between cerebral choline and renal dysfunction in chronic renal failure.
Sasaki O; Hattori N; Nakahama H; Inoue N; Nakamura S; Inenaga T; Kohno S; Sawada T; Kawano Y
Neuroradiology; 2006 May; 48(5):300-6. PubMed ID: 16586119
[TBL] [Abstract][Full Text] [Related]
5. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy.
Geissler A; Fründ R; Schölmerich J; Feuerbach S; Zietz B
Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):421-7. PubMed ID: 14614649
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
7. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
Taylor MJ; Schweinsburg BC; Alhassoon OM; Gongvatana A; Brown GG; Young-Casey C; Letendre SL; Grant I;
J Neurovirol; 2007 Apr; 13(2):150-9. PubMed ID: 17505983
[TBL] [Abstract][Full Text] [Related]
8. Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study.
Schweinsburg BC; Taylor MJ; Videen JS; Alhassoon OM; Patterson TL; Grant I
Alcohol Clin Exp Res; 2000 May; 24(5):699-705. PubMed ID: 10832912
[TBL] [Abstract][Full Text] [Related]
9. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.
Pouwels PJ; Frahm J
Magn Reson Med; 1998 Jan; 39(1):53-60. PubMed ID: 9438437
[TBL] [Abstract][Full Text] [Related]
10. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
[TBL] [Abstract][Full Text] [Related]
12. Normalization of Cerebral Blood Flow, Neurochemicals, and White Matter Integrity after Kidney Transplantation.
Lepping RJ; Montgomery RN; Sharma P; Mahnken JD; Vidoni ED; Choi IY; Sarnak MJ; Brooks WM; Burns JM; Gupta A
J Am Soc Nephrol; 2021 Jan; 32(1):177-187. PubMed ID: 33067382
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proton magnetic resonance spectroscopy of focal brain lesions.
Wilken B; Dechent P; Herms J; Maxton C; Markakis E; Hanefeld F; Frahm J
Pediatr Neurol; 2000 Jul; 23(1):22-31. PubMed ID: 10963966
[TBL] [Abstract][Full Text] [Related]
14. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.
Wiedermann D; Schuff N; Matson GB; Soher BJ; Du AT; Maudsley AA; Weiner MW
Magn Reson Imaging; 2001 Oct; 19(8):1073-80. PubMed ID: 11711231
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of 1H-MRS in vivo.
Brooks WM; Friedman SD; Stidley CA
Magn Reson Med; 1999 Jan; 41(1):193-7. PubMed ID: 10025629
[TBL] [Abstract][Full Text] [Related]
16. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.
Videen JS; Michaelis T; Pinto P; Ross BD
J Clin Invest; 1995 Feb; 95(2):788-93. PubMed ID: 7860762
[TBL] [Abstract][Full Text] [Related]
17. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy.
Lee CW; Lee JH; Kim JJ; Park SW; Hong MK; Kim ST; Lim TH; Park SJ
J Am Coll Cardiol; 1999 Apr; 33(5):1196-202. PubMed ID: 10193716
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
19. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease.
Brockmann K; Dechent P; Wilken B; Rusch O; Frahm J; Hanefeld F
Neurology; 2003 Mar; 60(5):819-25. PubMed ID: 12629240
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure.
Lee CW; Lee JH; Lim TH; Yang HS; Hong MK; Song JK; Park SW; Park SJ; Kim JJ
Circulation; 2001 Jun; 103(23):2784-7. PubMed ID: 11401932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
